What does endoscopy pre-procedure workflow software do?
Endoscopy pre-procedure workflow software automates the patient journey from booking confirmation to procedure day, so every patient gets the right bowel-prep instructions, completes the correct medication steps (GLP-1 cessation, anticoagulant hold or bridge, insulin and diabetes adjustment), gives consent, and arrives ready. Aescia for Clinics is a clinician-authored platform in this category that runs one pathway covering prep, medication overlays, reminders, consent, and prep-night confirmation, rather than a separate tool for each.
Aescia for Clinics is pre-first-customer and is not a medical device. It delivers clinician-authored steps; it does not propose or make clinical decisions.
From booking to procedure day, one pathway.
- At bookingThe patient is enrolled on the pathway for their procedure and their language. Communication consent is captured up front (TCPA-aware for US SMS). No portal login is forced.
- Intake and screeningA structured intake flags GLP-1 agonists, anticoagulants and antiplatelets, diabetes and insulin, and prior inadequate preparation, so the clinic’s authored rule for each can fire.
- Through the prep windowTimed reminders and prep coaching land on the schedule the pathway defines, with medication-hold and adjustment steps surfaced at the right time rather than at booking.
- Prep nightThe patient confirms readiness, including a structured photo check, so the front desk sees who is genuinely ready before the day of the list.
- Day of procedureA prioritised readiness view shows who is prepared, who needs a call, and which slots are at risk, so staff work exceptions rather than the whole list.
- After the procedureSurveillance recall and the next-interval reminder are tracked against guideline intervals, so the follow-up does not drift.
The steps a complete endoscopy pathway has to handle.
Bowel preparation
Clinician-authored prep instructions for your protocol, timed and coached, in the patient’s language.
GLP-1 peri-procedural handling
GLP-1 agonists (semaglutide, tirzepatide, liraglutide) flagged and the cessation overlay applied per the 2024 multi-society guidance.
Anticoagulant and antiplatelet handling
Blood thinners flagged on intake; the clinic’s hold or bridge rule surfaced to the patient at the right time.
Diabetes and insulin adjustment
Diabetic medications flagged; the clinic’s fasting-day adjustment rule delivered, with morning-list scheduling supported.
Consent capture
Communication opt-in and a structured prep-acknowledgment step, captured before reminders fire.
Surveillance and recall
Next-interval recall tracked against USMSTF and NHMRC guideline intervals so follow-up does not drift.
Deep dives: GLP-1 prep, blood thinners and diabetes, bowel prep, and no-show reduction.
Clinician-authored, explainable, and guideline-traced.
Pathways start from published evidence-based guidelines for the specialty: USMSTF and NHMRC for surveillance intervals, the 2024 multi-society guidance for GLP-1 peri-procedural handling, regional bowel-preparation protocols, and society anticoagulation guidance. A practising clinician authors the rule set against those guidelines, and every pathway carries a named clinical author and a documented guideline trail.
The rules are stress-tested against simulated synthetic-patient cohorts before they touch a real patient, so edge cases such as a diabetic patient on insulin who is also on a GLP-1 agonist surface and are resolved in the rule editor rather than in the front-desk call queue. The clinical alerts a patient or clinician sees run on these clinician-authored, explainable rules, not a black box, which is part of why Aescia for Clinics is not a medical device. Aescia does use machine learning for back-end analysis and operational tooling, like the procedure-length risk score on the roadmap below, but that analysis is advisory and is never the patient-facing clinical logic.
A procedure-length risk score, to plan the list before the day.
A colonoscopy that runs long pushes the rest of the list back, causing late starts, overruns, and downstream cancellations. We are building a risk score that flags, before the day, which cases are likely to run long or be technically difficult, so the list can be planned around them rather than discovered in real time.
It is a back-end, operational tool, not a clinical decision and not patient-facing. It draws on factors already known to track with longer or harder procedures: a patient’s previous colonoscopy duration and whether it was completed, prior Boston Bowel Preparation Scale (BBPS) scores, and other history. It surfaces the score and its main drivers to your schedulers; the team decides how to build the list.
This is the kind of machine-learning analysis Aescia keeps separate from the clinician-authored alert rules that drive patient care. It is planned, not built, and we will not put a number on its accuracy until we have measured it.
- Product
- Aescia for Clinics
- Category
- Pre-procedure patient-pathway software for endoscopy ambulatory surgery centers (ASCs).
- Founded
- 2025.
- Headquarters
- Sydney, Australia and Montréal, Canada.
- Regulatory status
- Aescia for Clinics is not a medical device. Its sibling product, Aescia for Hospitals, is an investigational software as a medical device, intended for Class IIa classification under the Australian TGA. No device application has been lodged for either product.
- Clinical evidence
- SAFE-Discharge trial (ACTRN12625001425482) at Royal Prince Alfred Hospital, Sydney, evaluating the Hospitals product across the 30-day post-discharge window.
- Integration targets
- Designed to work alongside common endoscopy systems including Provation, EndoWorks, and gGastro. No integration is live yet; Aescia is pre-first-customer, and any data exchange is scoped per customer.
- Pricing
- United States: US$8 per scope at the institutional tier; US$6 per scope for multi-state aggregators above 50,000 scopes per year. No per-seat pricing.
- Deployment stage
- Pre-first-customer. Clinics customers engage through the design-partner program, which runs free or under a money-back rebate until Aescia delivers measurable net benefit against the ASC’s own baseline.
See whether Aescia fits your ASC. The design-partner pilot runs free or under a money-back rebate until Aescia delivers measurable net benefit against your own baseline.